LXRX
Lexicon Pharmaceuticals Inc
1.90$
+5.8%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 390.6% | 73.2% | 196.8% | 2.1% | 3.9% | 1.0% | 8.0% | 18,471.8% | 37,781.3% | 4,898.0% | 2.0% | 0.6% | |
| -290.6% | 26.8% | -96.8% | 97.9% | 96.1% | 99.0% | 92.0% | -18,371.8% | -37,681.3% | -4,798.0% | 98.0% | 99.4% | |
| 390.6% | 73.2% | 213.8% | 173.6% | 158.6% | 28.5% | 640.2% | 18,471.8% | 37,997.1% | 4,890.9% | 271.8% | 122.7% | |
| 84.9% | 18.3% | 51.7% | 73.3% | 100.9% | 17.6% | 0.2% | 10,853.0% | 34,592.1% | 8,115.0% | 460.4% | 74.9% | |
| 475.6% | 91.5% | 265.4% | 246.9% | 259.5% | 55.1% | 291.2% | 10,853.0% | 34,807.9% | 9,466.9% | 732.2% | 197.7% | |
| -439.2% | 1.1% | -164.6% | -151.3% | -163.4% | 43.9% | -199.2% | -29,224.8% | -72,489.2% | -14,265.0% | -634.2% | -98.2% | |
| 9.9% | 5.2% | 7.9% | 7.7% | 32.9% | 6.4% | 60.6% | 269.1% | 2,000.0% | 1,088.1% | 50.1% | 16.7% | |
| -439.2% | -3.6% | -169.7% | -156.9% | -190.7% | 38.5% | -244.1% | -29,449.0% | -73,341.0% | -14,710.9% | -644.8% | -101.1% | |
| -0.3% | 4.6% | 5.4% | -14.0% | 5.5% | -1.9% | 48.4% | 171.1% | 851.8% | 32.1% | -644.8% | – | |
| -438.8% | -3.6% | -169.7% | -142.9% | -190.7% | 40.4% | -244.1% | -29,449.0% | -73,341.0% | -14,710.9% | -644.8% | -101.1% | |
| -420.9% | 9.0% | -151.0% | -138.7% | -152.0% | 46.1% | -171.3% | -29,081.9% | -71,966.2% | -14,099.3% | -592.9% | -83.1% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.